Active Ingredient(s): Epirubicin
FDA Approved: * September 15, 1999
Pharm Company: * PFIZER INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ellence Overview

Epirubicin is an anthracycline drug used for chemotherapy. It can be used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. It is marketed by Pfizer under the trade name Ellence in the US and Pharmorubicin or Epirubicin Ebewe elsewhere. Similarly to other anthracyclines, epirubicin acts by intercalating DNA strands. Intercalation results in complex formation which inhibits DNA and RNA synthesis. It also triggers DNA cleavage b...

Read more Ellence Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Epirubicin

Recent Ellence Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 200mg, 200mg/100ml (2mg/ml), 200mg/vial, 2mg/ml, 2mg/ml (200mg/100ml), 2mg/ml (50mg/25ml), 50mg, 50mg/25ml (2mg/ml), 50mg/vial
  • Powder: 200mg/vial, 50mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ellence: (2 results)

Sorted by National Drug Code
  • 0009-5091 Ellence 2 mg/ml Intravenous Injection, Solution by Pharmacia and Upjohn Company
  • 0009-5093 Ellence 2 mg/ml Intravenous Injection, Solution by Pharmacia and Upjohn Company

Other drugs which contain Epirubicin or a similar ingredient: (1 result)